Method for inhibiting infection of human T-cells
Patent 4840941 Issued on June 20, 1989. Estimated Expiration Date: 
January 15, 2008. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
January 15, 2008. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesModulators of the complement system comprising polyhexaose arylene sulfate derivatives Composition of matter from Cryptosiphonia woodii useful for the treatment of herpes simplex virus Synthetic immunoregulators and methods of use and preparation Therapeutic agent for the use in cancer treatment Membrane polysaccharides which are useful as immunostimulants Patent #: 4734403 InventorsAssigneeApplicationNo. 07/144131 filed on 01/15/1988US Classes:514/59, Dextran or derivative514/54, Polysaccharide514/55, Chitin or derivative514/56, Heparin or derivative514/60, Starch or derivative536/20, Chitin or derivative536/21, Heparin or derivative536/51, Dextran derivatives536/54, Sulfur containing536/58EstersExaminersPrimary: Griffin, Ronald W.Assistant: Carson, Nancy S. Attorney, Agent or FirmInternational ClassesA61K 31/715 (20060101)C07H 11/00 (20060101) Foreign Application Priority Data1986-04-04 JPAbstractMethod of treatment of diseases caused by retroviruses which comprises administering therapeutically effective amount of a natural or synthetic oligo- or polysaccharide having at least one S-oxoacid group attached to the saccharic carbon atom through a linking group of lower molecular weight or a pharmaceutically acceptable salt thereof to a subject in need of such treatment.Other References
|
| ||||||||||||||
